Debanjana Chatterjee
Stock Analyst at JonesTrading
(4.94)
# 139
Out of 4,334 analysts
241
Total ratings
68.4%
Success rate
45.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debanjana Chatterjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPTEY Opthea Limited | Rated: Hold | n/a | $0.035 | - | 8 | May 22, 2026 | |
| ABSI Absci | Maintained: Buy | $11 | $5.10 | +115.69% | 17 | May 22, 2026 | |
| SYRE Spyre Therapeutics | Maintained: Buy | $95 | $74.05 | +28.29% | 17 | May 18, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $31 → $26 | $7.09 | +266.71% | 15 | May 14, 2026 | |
| SION Sionna Therapeutics | Maintained: Buy | $63 | $41.13 | +53.17% | 7 | May 13, 2026 | |
| TVRD Tvardi Therapeutics | Reiterated: Buy | $12 | $3.57 | +236.13% | 16 | May 12, 2026 | |
| ABCL AbCellera Biologics | Reiterated: Buy | $11 → $13 | $5.20 | +150.00% | 4 | May 12, 2026 | |
| EVAX Evaxion | Maintained: Buy | $10 | $4.08 | +145.10% | 3 | May 8, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Buy | $26 | $13.89 | +87.19% | 10 | May 8, 2026 | |
| ARMP Armata Pharmaceuticals | Reiterated: Buy | $20 | $8.36 | +139.23% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $12.93 | +232.56% | 22 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $14.13 | +69.85% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $39 → $27 | $26.79 | +0.78% | 20 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $12.60 | +130.16% | 26 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.71 | +192.40% | 1 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 → $52 | $29.68 | +75.20% | 11 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $16.37 | +9.96% | 10 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.26 | +134.74% | 18 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.3151 | - | 11 | Aug 11, 2025 |
Opthea Limited
May 22, 2026
Rated: Hold
Price Target: n/a
Current: $0.035
Upside: -
Absci
May 22, 2026
Maintained: Buy
Price Target: $11
Current: $5.10
Upside: +115.69%
Spyre Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $95
Current: $74.05
Upside: +28.29%
Sagimet Biosciences
May 14, 2026
Reiterated: Buy
Price Target: $31 → $26
Current: $7.09
Upside: +266.71%
Sionna Therapeutics
May 13, 2026
Maintained: Buy
Price Target: $63
Current: $41.13
Upside: +53.17%
Tvardi Therapeutics
May 12, 2026
Reiterated: Buy
Price Target: $12
Current: $3.57
Upside: +236.13%
AbCellera Biologics
May 12, 2026
Reiterated: Buy
Price Target: $11 → $13
Current: $5.20
Upside: +150.00%
Evaxion
May 8, 2026
Maintained: Buy
Price Target: $10
Current: $4.08
Upside: +145.10%
Contineum Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $26
Current: $13.89
Upside: +87.19%
Armata Pharmaceuticals
May 7, 2026
Reiterated: Buy
Price Target: $20
Current: $8.36
Upside: +139.23%
May 6, 2026
Reiterated: Buy
Price Target: $43
Current: $12.93
Upside: +232.56%
May 6, 2026
Maintained: Buy
Price Target: $24
Current: $14.13
Upside: +69.85%
Apr 29, 2026
Downgraded: Hold
Price Target: $39 → $27
Current: $26.79
Upside: +0.78%
Apr 27, 2026
Reiterated: Buy
Price Target: $29
Current: $12.60
Upside: +130.16%
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $1.71
Upside: +192.40%
Apr 15, 2026
Reiterated: Buy
Price Target: $48 → $52
Current: $29.68
Upside: +75.20%
Mar 25, 2026
Reiterated: Buy
Price Target: $17 → $18
Current: $16.37
Upside: +9.96%
Mar 10, 2026
Reiterated: Buy
Price Target: $10
Current: $4.26
Upside: +134.74%
Aug 11, 2025
Maintained: Hold
Price Target: n/a
Current: $0.3151
Upside: -